nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Photophobia—Vinblastine—head and neck cancer	0.0183	0.0183	CcSEcCtD
Perflutren—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.0159	0.0159	CcSEcCtD
Perflutren—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.0141	0.0141	CcSEcCtD
Perflutren—Leukocytosis—Fluorouracil—head and neck cancer	0.0136	0.0136	CcSEcCtD
Perflutren—Burning sensation—Docetaxel—head and neck cancer	0.0133	0.0133	CcSEcCtD
Perflutren—Face oedema—Hydroxyurea—head and neck cancer	0.0124	0.0124	CcSEcCtD
Perflutren—Rash erythematous—Docetaxel—head and neck cancer	0.012	0.012	CcSEcCtD
Perflutren—Photophobia—Fluorouracil—head and neck cancer	0.012	0.012	CcSEcCtD
Perflutren—Coma—Fluorouracil—head and neck cancer	0.0117	0.0117	CcSEcCtD
Perflutren—Myocardial ischaemia—Docetaxel—head and neck cancer	0.0115	0.0115	CcSEcCtD
Perflutren—Rigors—Docetaxel—head and neck cancer	0.0113	0.0113	CcSEcCtD
Perflutren—Neuropathy peripheral—Vinblastine—head and neck cancer	0.0107	0.0107	CcSEcCtD
Perflutren—Swelling—Fluorouracil—head and neck cancer	0.0105	0.0105	CcSEcCtD
Perflutren—Haemoglobin—Vinblastine—head and neck cancer	0.00982	0.00982	CcSEcCtD
Perflutren—Haemorrhage—Vinblastine—head and neck cancer	0.00977	0.00977	CcSEcCtD
Perflutren—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00973	0.00973	CcSEcCtD
Perflutren—Hypoaesthesia—Vinblastine—head and neck cancer	0.00972	0.00972	CcSEcCtD
Perflutren—Pharyngitis—Vinblastine—head and neck cancer	0.00969	0.00969	CcSEcCtD
Perflutren—Hearing impaired—Docetaxel—head and neck cancer	0.00968	0.00968	CcSEcCtD
Perflutren—Injection site reaction—Docetaxel—head and neck cancer	0.00916	0.00916	CcSEcCtD
Perflutren—Haemoglobin—Hydroxyurea—head and neck cancer	0.00895	0.00895	CcSEcCtD
Perflutren—Influenza like illness—Docetaxel—head and neck cancer	0.00895	0.00895	CcSEcCtD
Perflutren—Haemorrhage—Hydroxyurea—head and neck cancer	0.00891	0.00891	CcSEcCtD
Perflutren—Cardiac arrest—Fluorouracil—head and neck cancer	0.00881	0.00881	CcSEcCtD
Perflutren—Dry skin—Fluorouracil—head and neck cancer	0.00849	0.00849	CcSEcCtD
Perflutren—Angiopathy—Hydroxyurea—head and neck cancer	0.00808	0.00808	CcSEcCtD
Perflutren—Chills—Hydroxyurea—head and neck cancer	0.00799	0.00799	CcSEcCtD
Perflutren—Eosinophilia—Fluorouracil—head and neck cancer	0.00793	0.00793	CcSEcCtD
Perflutren—Ill-defined disorder—Vinblastine—head and neck cancer	0.00789	0.00789	CcSEcCtD
Perflutren—Erythema—Hydroxyurea—head and neck cancer	0.00775	0.00775	CcSEcCtD
Perflutren—Malaise—Vinblastine—head and neck cancer	0.00767	0.00767	CcSEcCtD
Perflutren—Vertigo—Vinblastine—head and neck cancer	0.00764	0.00764	CcSEcCtD
Perflutren—Leukopenia—Vinblastine—head and neck cancer	0.00761	0.00761	CcSEcCtD
Perflutren—Swelling—Docetaxel—head and neck cancer	0.00758	0.00758	CcSEcCtD
Perflutren—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00738	0.00738	CcSEcCtD
Perflutren—Convulsion—Vinblastine—head and neck cancer	0.00737	0.00737	CcSEcCtD
Perflutren—Hypertension—Vinblastine—head and neck cancer	0.00734	0.00734	CcSEcCtD
Perflutren—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00719	0.00719	CcSEcCtD
Perflutren—Discomfort—Vinblastine—head and neck cancer	0.00715	0.00715	CcSEcCtD
Perflutren—Hot flush—Docetaxel—head and neck cancer	0.00715	0.00715	CcSEcCtD
Perflutren—Menopausal symptoms—Docetaxel—head and neck cancer	0.00709	0.00709	CcSEcCtD
Perflutren—Atrial fibrillation—Docetaxel—head and neck cancer	0.00706	0.00706	CcSEcCtD
Perflutren—Visual disturbance—Docetaxel—head and neck cancer	0.00706	0.00706	CcSEcCtD
Perflutren—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.007	0.007	CcSEcCtD
Perflutren—Malaise—Hydroxyurea—head and neck cancer	0.00699	0.00699	CcSEcCtD
Perflutren—Conjunctivitis—Fluorouracil—head and neck cancer	0.00694	0.00694	CcSEcCtD
Perflutren—Leukopenia—Hydroxyurea—head and neck cancer	0.00694	0.00694	CcSEcCtD
Perflutren—Convulsion—Hydroxyurea—head and neck cancer	0.00672	0.00672	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00656	0.00656	CcSEcCtD
Perflutren—Discomfort—Hydroxyurea—head and neck cancer	0.00652	0.00652	CcSEcCtD
Perflutren—Haemoglobin—Fluorouracil—head and neck cancer	0.00644	0.00644	CcSEcCtD
Perflutren—Rhinitis—Fluorouracil—head and neck cancer	0.00643	0.00643	CcSEcCtD
Perflutren—Haemorrhage—Fluorouracil—head and neck cancer	0.00641	0.00641	CcSEcCtD
Perflutren—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00638	0.00638	CcSEcCtD
Perflutren—Pharyngitis—Fluorouracil—head and neck cancer	0.00636	0.00636	CcSEcCtD
Perflutren—Oedema—Hydroxyurea—head and neck cancer	0.00633	0.00633	CcSEcCtD
Perflutren—Paraesthesia—Vinblastine—head and neck cancer	0.00623	0.00623	CcSEcCtD
Perflutren—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00621	0.00621	CcSEcCtD
Perflutren—Skin disorder—Hydroxyurea—head and neck cancer	0.00615	0.00615	CcSEcCtD
Perflutren—Dry skin—Docetaxel—head and neck cancer	0.00613	0.00613	CcSEcCtD
Perflutren—Cramp muscle—Docetaxel—head and neck cancer	0.00602	0.00602	CcSEcCtD
Perflutren—Pain—Vinblastine—head and neck cancer	0.00593	0.00593	CcSEcCtD
Perflutren—Arrhythmia—Fluorouracil—head and neck cancer	0.00573	0.00573	CcSEcCtD
Perflutren—Feeling abnormal—Vinblastine—head and neck cancer	0.00572	0.00572	CcSEcCtD
Perflutren—Bronchospasm—Docetaxel—head and neck cancer	0.00569	0.00569	CcSEcCtD
Perflutren—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00567	0.00567	CcSEcCtD
Perflutren—Dyspnoea—Hydroxyurea—head and neck cancer	0.00564	0.00564	CcSEcCtD
Perflutren—Erythema—Fluorouracil—head and neck cancer	0.00558	0.00558	CcSEcCtD
Perflutren—Dyspepsia—Hydroxyurea—head and neck cancer	0.00557	0.00557	CcSEcCtD
Perflutren—Abdominal pain—Vinblastine—head and neck cancer	0.00549	0.00549	CcSEcCtD
Perflutren—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00546	0.00546	CcSEcCtD
Perflutren—Fatigue—Hydroxyurea—head and neck cancer	0.00546	0.00546	CcSEcCtD
Perflutren—Pain—Hydroxyurea—head and neck cancer	0.00541	0.00541	CcSEcCtD
Perflutren—Vision blurred—Fluorouracil—head and neck cancer	0.00526	0.00526	CcSEcCtD
Perflutren—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00521	0.00521	CcSEcCtD
Perflutren—Hypersensitivity—Vinblastine—head and neck cancer	0.00511	0.00511	CcSEcCtD
Perflutren—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00505	0.00505	CcSEcCtD
Perflutren—Conjunctivitis—Docetaxel—head and neck cancer	0.00501	0.00501	CcSEcCtD
Perflutren—Body temperature increased—Hydroxyurea—head and neck cancer	0.005	0.005	CcSEcCtD
Perflutren—Leukopenia—Fluorouracil—head and neck cancer	0.005	0.005	CcSEcCtD
Perflutren—Asthenia—Vinblastine—head and neck cancer	0.00498	0.00498	CcSEcCtD
Perflutren—Convulsion—Fluorouracil—head and neck cancer	0.00484	0.00484	CcSEcCtD
Perflutren—Chest pain—Fluorouracil—head and neck cancer	0.00475	0.00475	CcSEcCtD
Perflutren—Myalgia—Fluorouracil—head and neck cancer	0.00475	0.00475	CcSEcCtD
Perflutren—Diarrhoea—Vinblastine—head and neck cancer	0.00475	0.00475	CcSEcCtD
Perflutren—Discomfort—Fluorouracil—head and neck cancer	0.00469	0.00469	CcSEcCtD
Perflutren—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00466	0.00466	CcSEcCtD
Perflutren—Haemoglobin—Docetaxel—head and neck cancer	0.00465	0.00465	CcSEcCtD
Perflutren—Rhinitis—Docetaxel—head and neck cancer	0.00464	0.00464	CcSEcCtD
Perflutren—Haemorrhage—Docetaxel—head and neck cancer	0.00463	0.00463	CcSEcCtD
Perflutren—Hypoaesthesia—Docetaxel—head and neck cancer	0.0046	0.0046	CcSEcCtD
Perflutren—Pharyngitis—Docetaxel—head and neck cancer	0.00459	0.00459	CcSEcCtD
Perflutren—Dizziness—Vinblastine—head and neck cancer	0.00459	0.00459	CcSEcCtD
Perflutren—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00456	0.00456	CcSEcCtD
Perflutren—Oedema—Fluorouracil—head and neck cancer	0.00456	0.00456	CcSEcCtD
Perflutren—Connective tissue disorder—Docetaxel—head and neck cancer	0.00455	0.00455	CcSEcCtD
Perflutren—Asthenia—Hydroxyurea—head and neck cancer	0.00454	0.00454	CcSEcCtD
Perflutren—Nervous system disorder—Fluorouracil—head and neck cancer	0.00447	0.00447	CcSEcCtD
Perflutren—Visual impairment—Docetaxel—head and neck cancer	0.00446	0.00446	CcSEcCtD
Perflutren—Tachycardia—Fluorouracil—head and neck cancer	0.00445	0.00445	CcSEcCtD
Perflutren—Vomiting—Vinblastine—head and neck cancer	0.00441	0.00441	CcSEcCtD
Perflutren—Headache—Vinblastine—head and neck cancer	0.00435	0.00435	CcSEcCtD
Perflutren—Diarrhoea—Hydroxyurea—head and neck cancer	0.00433	0.00433	CcSEcCtD
Perflutren—Eye disorder—Docetaxel—head and neck cancer	0.00432	0.00432	CcSEcCtD
Perflutren—Cardiac disorder—Docetaxel—head and neck cancer	0.00429	0.00429	CcSEcCtD
Perflutren—Flushing—Docetaxel—head and neck cancer	0.00429	0.00429	CcSEcCtD
Perflutren—Hypotension—Fluorouracil—head and neck cancer	0.00426	0.00426	CcSEcCtD
Perflutren—Angiopathy—Docetaxel—head and neck cancer	0.0042	0.0042	CcSEcCtD
Perflutren—Dizziness—Hydroxyurea—head and neck cancer	0.00418	0.00418	CcSEcCtD
Perflutren—Immune system disorder—Docetaxel—head and neck cancer	0.00418	0.00418	CcSEcCtD
Perflutren—Mediastinal disorder—Docetaxel—head and neck cancer	0.00417	0.00417	CcSEcCtD
Perflutren—Chills—Docetaxel—head and neck cancer	0.00415	0.00415	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00415	0.00415	CcSEcCtD
Perflutren—Arrhythmia—Docetaxel—head and neck cancer	0.00413	0.00413	CcSEcCtD
Perflutren—Nausea—Vinblastine—head and neck cancer	0.00412	0.00412	CcSEcCtD
Perflutren—Paraesthesia—Fluorouracil—head and neck cancer	0.00409	0.00409	CcSEcCtD
Perflutren—Dyspnoea—Fluorouracil—head and neck cancer	0.00406	0.00406	CcSEcCtD
Perflutren—Erythema—Docetaxel—head and neck cancer	0.00403	0.00403	CcSEcCtD
Perflutren—Vomiting—Hydroxyurea—head and neck cancer	0.00402	0.00402	CcSEcCtD
Perflutren—Dyspepsia—Fluorouracil—head and neck cancer	0.00401	0.00401	CcSEcCtD
Perflutren—Rash—Hydroxyurea—head and neck cancer	0.00399	0.00399	CcSEcCtD
Perflutren—Dermatitis—Hydroxyurea—head and neck cancer	0.00399	0.00399	CcSEcCtD
Perflutren—Headache—Hydroxyurea—head and neck cancer	0.00396	0.00396	CcSEcCtD
Perflutren—Dysgeusia—Docetaxel—head and neck cancer	0.00394	0.00394	CcSEcCtD
Perflutren—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00393	0.00393	CcSEcCtD
Perflutren—Back pain—Docetaxel—head and neck cancer	0.0039	0.0039	CcSEcCtD
Perflutren—Pain—Fluorouracil—head and neck cancer	0.0039	0.0039	CcSEcCtD
Perflutren—Muscle spasms—Docetaxel—head and neck cancer	0.00387	0.00387	CcSEcCtD
Perflutren—Nausea—Hydroxyurea—head and neck cancer	0.00376	0.00376	CcSEcCtD
Perflutren—Feeling abnormal—Fluorouracil—head and neck cancer	0.00375	0.00375	CcSEcCtD
Perflutren—Urticaria—Fluorouracil—head and neck cancer	0.00362	0.00362	CcSEcCtD
Perflutren—Syncope—Docetaxel—head and neck cancer	0.00361	0.00361	CcSEcCtD
Perflutren—Leukopenia—Docetaxel—head and neck cancer	0.00361	0.00361	CcSEcCtD
Perflutren—Body temperature increased—Fluorouracil—head and neck cancer	0.0036	0.0036	CcSEcCtD
Perflutren—Palpitations—Docetaxel—head and neck cancer	0.00356	0.00356	CcSEcCtD
Perflutren—Loss of consciousness—Docetaxel—head and neck cancer	0.00354	0.00354	CcSEcCtD
Perflutren—Cough—Docetaxel—head and neck cancer	0.00352	0.00352	CcSEcCtD
Perflutren—Convulsion—Docetaxel—head and neck cancer	0.00349	0.00349	CcSEcCtD
Perflutren—Hypertension—Docetaxel—head and neck cancer	0.00348	0.00348	CcSEcCtD
Perflutren—Myalgia—Docetaxel—head and neck cancer	0.00343	0.00343	CcSEcCtD
Perflutren—Arthralgia—Docetaxel—head and neck cancer	0.00343	0.00343	CcSEcCtD
Perflutren—Chest pain—Docetaxel—head and neck cancer	0.00343	0.00343	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00341	0.00341	CcSEcCtD
Perflutren—Hypersensitivity—Fluorouracil—head and neck cancer	0.00336	0.00336	CcSEcCtD
Perflutren—Dry mouth—Docetaxel—head and neck cancer	0.00335	0.00335	CcSEcCtD
Perflutren—Oedema—Docetaxel—head and neck cancer	0.00329	0.00329	CcSEcCtD
Perflutren—Anaphylactic shock—Docetaxel—head and neck cancer	0.00329	0.00329	CcSEcCtD
Perflutren—Shock—Docetaxel—head and neck cancer	0.00323	0.00323	CcSEcCtD
Perflutren—Nervous system disorder—Docetaxel—head and neck cancer	0.00322	0.00322	CcSEcCtD
Perflutren—Pruritus—Fluorouracil—head and neck cancer	0.00322	0.00322	CcSEcCtD
Perflutren—Tachycardia—Docetaxel—head and neck cancer	0.00321	0.00321	CcSEcCtD
Perflutren—Skin disorder—Docetaxel—head and neck cancer	0.00319	0.00319	CcSEcCtD
Perflutren—Diarrhoea—Fluorouracil—head and neck cancer	0.00312	0.00312	CcSEcCtD
Perflutren—Hypotension—Docetaxel—head and neck cancer	0.00307	0.00307	CcSEcCtD
Perflutren—Dizziness—Fluorouracil—head and neck cancer	0.00301	0.00301	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.003	0.003	CcSEcCtD
Perflutren—Paraesthesia—Docetaxel—head and neck cancer	0.00295	0.00295	CcSEcCtD
Perflutren—Dyspnoea—Docetaxel—head and neck cancer	0.00293	0.00293	CcSEcCtD
Perflutren—Vomiting—Fluorouracil—head and neck cancer	0.0029	0.0029	CcSEcCtD
Perflutren—Dyspepsia—Docetaxel—head and neck cancer	0.00289	0.00289	CcSEcCtD
Perflutren—Rash—Fluorouracil—head and neck cancer	0.00287	0.00287	CcSEcCtD
Perflutren—Dermatitis—Fluorouracil—head and neck cancer	0.00287	0.00287	CcSEcCtD
Perflutren—Headache—Fluorouracil—head and neck cancer	0.00285	0.00285	CcSEcCtD
Perflutren—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00284	0.00284	CcSEcCtD
Perflutren—Fatigue—Docetaxel—head and neck cancer	0.00283	0.00283	CcSEcCtD
Perflutren—Pain—Docetaxel—head and neck cancer	0.00281	0.00281	CcSEcCtD
Perflutren—Feeling abnormal—Docetaxel—head and neck cancer	0.00271	0.00271	CcSEcCtD
Perflutren—Nausea—Fluorouracil—head and neck cancer	0.00271	0.00271	CcSEcCtD
Perflutren—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00269	0.00269	CcSEcCtD
Perflutren—Abdominal pain—Docetaxel—head and neck cancer	0.0026	0.0026	CcSEcCtD
Perflutren—Body temperature increased—Docetaxel—head and neck cancer	0.0026	0.0026	CcSEcCtD
Perflutren—Hypersensitivity—Docetaxel—head and neck cancer	0.00242	0.00242	CcSEcCtD
Perflutren—Asthenia—Docetaxel—head and neck cancer	0.00236	0.00236	CcSEcCtD
Perflutren—Pruritus—Docetaxel—head and neck cancer	0.00233	0.00233	CcSEcCtD
Perflutren—Diarrhoea—Docetaxel—head and neck cancer	0.00225	0.00225	CcSEcCtD
Perflutren—Dizziness—Docetaxel—head and neck cancer	0.00217	0.00217	CcSEcCtD
Perflutren—Vomiting—Docetaxel—head and neck cancer	0.00209	0.00209	CcSEcCtD
Perflutren—Rash—Docetaxel—head and neck cancer	0.00207	0.00207	CcSEcCtD
Perflutren—Dermatitis—Docetaxel—head and neck cancer	0.00207	0.00207	CcSEcCtD
Perflutren—Headache—Docetaxel—head and neck cancer	0.00206	0.00206	CcSEcCtD
Perflutren—Nausea—Docetaxel—head and neck cancer	0.00195	0.00195	CcSEcCtD
